Tyramine

monoamine oxidase B ; Homo sapiens







33 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33992221 Direct minimally invasive enzymatic determination of tyramine in cheese using digital imaging. 2021 Jun 15 1
2 34784871 How to optimize the effectiveness and safety of Parkinson's disease therapy? - a systematic review of drugs interactions with food and dietary supplements. 2021 Nov 16 1
3 32072299 Colorimetric-enzymatic determination of tyramine by generation of gold nanoparticles. 2020 Feb 18 3
4 32942081 A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review. 2020 Nov 15 1
5 29417334 Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease. 2018 Nov 1
6 27118978 Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor. 2016 1
7 24720993 An automated sequential injection spectrophotometric method for evaluation of tyramine oxidase inhibitory activity of some flavonoids. 2014 May 1
8 25017965 Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies. 2014 Oct 1
9 21628600 The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge? 2012 May 1
10 19006188 Selective MAO-B inhibitors have low potential for the tyramine effect. 2010 Jan 15 1
11 20445015 Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. 2010 Dec 1
12 18678789 Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease. 2008 Sep 1
13 16807522 The association of monoamine oxidase B functional polymorphism with postoperative pain intensity. 2006 Jun 2
14 12897643 Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition. 2003 Jul-Aug 1
15 11259630 Regulation of human monoamine oxidase B gene by Sp1 and Sp3. 2001 Apr 1
16 10777699 Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. 2000 Apr 29 1
17 10498294 Reactive oxygen species production by monoamine oxidases in intact cells. 1999 May 1
18 9572675 Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication, and disease. 1998 Jun 1
19 8573115 Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B. 1996 Jan 5 1
20 8695909 The monoamine regulon including syntheses of arylsulfatase and monoamine oxidase in bacteria. 1996 Jun 1
21 7955818 Kinetics and metabolism of p-tyramine during monoamine oxidase inhibition by mofegiline. 1994 Nov 1
22 8390270 Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. 1993 1
23 1609337 Recent advances in antidepressant drugs. 1992 Jun 6 1
24 1741773 Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data. 1991 Oct 24 1
25 1759390 [The role of monoamine oxidase in the regulation of mitochondrial energy functions]. 1991 Sep-Oct 1
26 22282124 Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor. 1991 Jan 1
27 2153484 Rapid enzymatic analysis of plasma for tyrosine. 1990 Jan 2
28 2503040 Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes. 1989 Aug 18 1
29 3266532 Design and early clinical evaluation of selective inhibitors of monoamine oxidase. 1988 1
30 3928010 Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. 1985 Jun 1
31 6627826 Oral absorption and concentration-effect relationship of tyramine with and without cimoxatone, a type-A specific inhibitor of monoamine oxidase. 1983 Nov 1
32 6791202 Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity. 1981 1
33 6791210 Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. 1981 1